Press Releases

 
Press Releases
  Date Title View
Jul 2, 2015
LYON, France, July 2, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Eric Soyer, Chief Financial Officer, has resigned from the Company to accept a top management position at a publicly traded biotechnology company. To ensure a smooth transition, Mr. Soyer will remain with the C...
Jun 9, 2015
LYON, France, June 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the installation of a Focal One system under a Revenue-per-procedure ("RPP") contract with the Martini-Klinik at the University Hospital Hamburg-Eppendorf (UKE) in Germany. The Martini-Klinik is the world's ...
May 12, 2015
1Q 2015 and Recent Operational Highlights Direct De Novo petition for Ablatherm HIFU submitted to the FDA in April 2015; Treatment-driven revenue from the HIFU division increased 17% year-over-year; Revenue for first quarter 2015 totaled EUR 6.2 million (USD 6.9 million); Canadian regulatory approval of F...
May 6, 2015
LYON, France, May 6, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the first quarter ended March 31, 2015 on Tuesday, May 12, 2015, after the close of trading. Company management will host a conference call on Wednesday, May 13,...
Apr 1, 2015
2014 and Recent Operational Highlights Record revenue in 2014 of EUR 26.8 million (USD 35.4 million); 11% growth over the previous year; Full-year HIFU revenue increased 70% over 2013; Strong Cash position of EUR 12.1 million (USD 14.7 million) as of December 31, 2014; Filing Direct De Novo petition for A...
Mar 31, 2015
LYON, France, March 31, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first sale of Focal One HIFU device to Jewish General Hospital, Montreal, Canada. This sale occurs only two months after the Company gained Health Canada's approval to market its Focal One HIFU device for foca...
Mar 26, 2015
LYON, France, March 26, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the Company's participation in a major collaborative liver cancer project aimed at developing innovative new therapies for this prevalent indication. "HECAM" (HEpatocellular CArcinoma Multi-technological) ...
Mar 17, 2015
LYON, France, March 17, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the fourth quarter and year ended December 31, 2014 on Thursday, April 2, 2015, during pre-market hours. Company management will host a conference call on Thu...
Mar 9, 2015
LYON, France, March 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that, based on a recent meeting with the U.S. Food and Drug Administration ("FDA"), the Company plans to seek clearance of Ablatherm HIFU by way of a Direct De Novo 510(k) application as opposed to the Pre-Market A...
Feb 26, 2015
LYON, France, Feb. 26, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced a multi-national strategic OEM partnership with Quanta System, a leading manufacturer of medical lasers for surgical and other applications. Under the agreement, Quanta will manufacture customized urological stone ...
1
... NextLast
= add release to Briefcase